About: NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1983

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1983 (uk) article scientifique publié en 1983 (fr) im Mai 1983 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1983 (ast) scientific article published on 01 May 1983 (en)
publication date	wds:Q71724130-50E8FBC6-90B6-46FD-ABD3-B86AAD374B1D
publication date	1983-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71724130-A09DD4E3-025B-4227-BB2A-28A1BA2200FF
language of work or name	English
author name string	wds:Q71724130-66C6156C-1432-469B-B003-765035C283F0 wds:Q71724130-B397C74E-3FD3-43FF-B1E5-7D0BFE12CB25 wds:Q71724130-BAEE69BD-332D-430D-A41D-AF2E2F6C506A wds:Q71724130-DD934CEE-D20B-4D6D-8531-076ED64A42ED wds:Q71724130-FDEE768A-131E-4E32-A277-BEA1B4A33F6C
author name string	H B Brewer E J Schaefer L A Zech R E Gregg D Schwartz
rdfs:label	NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (en) NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (nl)
skos:prefLabel	NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (en) NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (nl)
name	NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (en) NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (nl)
title	wds:Q71724130-870CEFBC-BF3C-4393-A78E-D0720AA7E796
title	NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment (en)
page(s)	wds:Q71724130-0DFA257A-7AC4-466D-891C-073CD784444A
page(s)	623-640
instance of	wds:Q71724130-1FD895AF-2E17-432F-8309-3E5B11C9F802
instance of	scholarly article
PubMed ID	wds:Q71724130-7A16B605-A166-4B66-90EA-E7A35D4C1E60
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6846977
PubMed ID	6846977
published in	wds:Q71724130-C0BF7CF5-6CA9-45E7-BA09-C886BFA0BA42
published in	Annals of Internal Medicine
issue	wds:Q71724130-937A89DC-5FC4-4453-9C27-90C0EC15C201
volume	wds:Q71724130-13D2D47C-4920-4CA4-A1FE-AD900CE0E599
issue	5 Pt 1
volume	98
DOI	wds:Q71724130-5C728B8E-0075-41E7-842D-45E65108C488
DOI	http://dx.doi.org/10.7326/0003-4819-98-5-623
DOI	10.7326/0003-4819-98-5-623
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71724130
is cites work of	Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia. Apolipoprotein E-4Philadelphia (Glu13—-Lys,Arg145—-Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors Familial apolipoprotein E deficiency Intestinally-derived lipoproteins: Metabolism and clinical significance Clustering of cardiovascular risk factors: targeting high-risk individuals Diabetes secondary to genetic disorders Evidence that triglycerides are an independent coronary heart disease risk factor Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe2 Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu). Role of fibrates in the management of hypertriglyceridemia The expression of type III hyperlipoproteinemia: involvement of lipolysis genes Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain. Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan Clinical features of type III hyperlipoproteinemia: analysis of 64 patients Apo E structure determines VLDL clearance and atherosclerosis risk in mice. Abnormal in vivo metabolism of apolipoprotein E4 in humans Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice Severe defect in clearing postprandial chylomicron remnants in dialysis patients Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein l Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients Long-term effects of simvastatin in familial dysbetalipoproteinaemia The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype Xanthoma striatum palmare as an early sign of familial type III hyperlipoproteinemia with an apoprotein E genotype epsilon2/epsilon2 In the absence of endogenous mouse apolipoprotein E, apolipoprotein E2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. ApoE deficiency: markedly decreased levels of cellular ApoE mRNA Plasma lipid concentrations: the concept of "normality" and its implications for detection of high cardiovascular risk Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation Association of an apolipoprotein E polymorphism with circulating cholesterols and hypertension: a meta-based Mendelian randomization analysis. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia. Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias Meta-based evidence for apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphism in association with hypertension among Chinese Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software